1. Home
  2. BHR vs EQ Comparison

BHR vs EQ Comparison

Compare BHR & EQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Braemar Hotels & Resorts Inc.

BHR

Braemar Hotels & Resorts Inc.

HOLD

Current Price

$1.76

Market Cap

127.7M

Sector

Real Estate

ML Signal

HOLD

Logo Equillium Inc.

EQ

Equillium Inc.

HOLD

Current Price

$1.75

Market Cap

140.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BHR
EQ
Founded
2013
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
127.7M
140.1M
IPO Year
2013
2018

Fundamental Metrics

Financial Performance
Metric
BHR
EQ
Price
$1.76
$1.75
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$8.00
AVG Volume (30 Days)
398.3K
541.1K
Earning Date
05-06-2026
05-25-2026
Dividend Yield
8.47%
N/A
EPS Growth
N/A
N/A
EPS
0.06
N/A
Revenue
$487,614,000.00
$41,095,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$30.33
N/A
Revenue Growth
13.03
N/A
52 Week Low
$1.72
$0.76
52 Week High
$3.19
$3.54

Technical Indicators

Market Signals
Indicator
BHR
EQ
Relative Strength Index (RSI) N/A N/A
Support Level N/A N/A
Resistance Level N/A N/A
Average True Range (ATR) 0.00 0.00
MACD 0.00 0.00
Stochastic Oscillator 0.00 0.00

Price Performance

Historical Comparison
BHR
EQ

About BHR Braemar Hotels & Resorts Inc.

Braemar Hotels & Resorts Inc is a real estate investment trust company that invests in high revenue per available room, or RevPAR, luxury hotels and resorts. The firm operates in various U.S. states such as California, Texas, Washington, Philadelphia, Florida, and Illinois as well as Washington, D.C. and St. Thomas, U.S. Virgin Islands. The company operates through its direct hotel investment segment of the hotel lodging industry. Its revenue streams include rooms, food and beverage, and other. The firm's hotels operate under various brands, such as Marriott, Hilton, Courtyard, and, among others.

About EQ Equillium Inc.

Equillium Inc is a biotechnology innovator developing novel therapies to treat severe autoimmune and inflammatory disorders with the mission to develop life-changing therapeutics for patients. It primary goal is to advance EQ504, a novel aryl hydrocarbon receptor, or AhR, modulator, into and through clinical development. The Company operates through a single operating and reportable segment focused on the business of developing novel therapies to treat severe autoimmune and inflammatory disorders, with the mission to develop life-changing therapeutics for patients. The Company manages all business activities on a consolidated basis.

Share on Social Networks: